Literature DB >> 6696498

Cirrhosis associated with multiple transfusions in thalassaemia.

G Jean, S Terzoli, R Mauri, L Borghetti, A Di Palma, A Piga, M Magliano, M Melevendi, M Cattaneo.   

Abstract

The study of surgical liver biopsy specimens obtained during splenectomy in 86 children with thalassaemia indicated that such patients may develop liver disease that evolves into cirrhosis. Histological characteristics suggest that it is post-necrotic cirrhosis. Onset of cirrhosis in some patients may occur as early as 7-8 years old, and at age about 15-16 years most children with thalassaemia show features of cirrhosis. In addition to fibrosis, hepatitis, or even aggressive hepatitis may develop as has also been observed in patients without thalassaemia who have undergone multiple transfusions. This study presents the current probable evolution of liver disease in patients with thalassaemia and may thus serve as a reference from which to evaluate any future progress in the treatment and care of patients with Cooley's disease.

Entities:  

Mesh:

Year:  1984        PMID: 6696498      PMCID: PMC1628419          DOI: 10.1136/adc.59.1.67

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  11 in total

1.  Post-transfusion hepatitis leading to chronic hepatitis.

Authors: 
Journal:  Gastroenterology       Date:  1978-10       Impact factor: 22.682

2.  Total management of thalassaemia major.

Authors:  B Modell
Journal:  Arch Dis Child       Date:  1977-06       Impact factor: 3.791

Review 3.  Chronic hepatitis: taxonomic, etiologic, and therapeutic problems.

Authors:  H Popper; F Schaffner
Journal:  Prog Liver Dis       Date:  1976

4.  Percutaneous liver biopsy and chronic liver disease in haemophiliacs.

Authors:  F E Preston; D R Triger; J C Underwood; G Bardhan; V E Mitchell; R M Stewart; E K Blackburn
Journal:  Lancet       Date:  1978-09-16       Impact factor: 79.321

Review 5.  Hemochromatosis: 1980 update.

Authors:  L W Powell; M L Bassett; J W Halliday
Journal:  Gastroenterology       Date:  1980-02       Impact factor: 22.682

6.  Precursor forms of penicillin-binding proteins 5 and 6 of E. coli cytoplasmic membrane.

Authors:  J M Pratt; I B Holland; B G Spratt
Journal:  Nature       Date:  1981-09-24       Impact factor: 49.962

7.  Role of chronic hepatitis in development of thalassaemic liver disease.

Authors:  G Masera; G Jean; G Gazzola; M Novakova
Journal:  Arch Dis Child       Date:  1976-09       Impact factor: 3.791

8.  Sequential study of liver biopsy in thalassaemia.

Authors:  G Masera; G Jean; V Conter; S Terzoli; R A Mauri; M Cazzaniga
Journal:  Arch Dis Child       Date:  1980-10       Impact factor: 3.791

9.  Liver disease complicating severe haemophilia in childhood.

Authors:  K M McGrath; J S Lilleyman; D R Triger; J C Underwood
Journal:  Arch Dis Child       Date:  1980-07       Impact factor: 3.791

10.  Iron chelation in transfusion-dependent thalassemia with chronic hepatitis.

Authors:  S De Virgiliis; P Cossu; G Sanna; F Frau; E Loi; R Lobrano; A Nucaro; C Toccafondi; G Cornacchia; A Loi; A Cao
Journal:  Acta Haematol       Date:  1982       Impact factor: 2.195

View more
  13 in total

1.  Hepatic iron quantitation and its relationship with disease measures and histologically assessed iron content.

Authors:  Shabbar Sajjad; Moises Garcia; Ahmed Malik; David H Van Thiel
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

2.  Liver injury due to iron overload in thalassemia: histopathologic and ultrastructural studies.

Authors:  K Thakerngpol; S Fucharoen; P Boonyaphipat; K Srisook; S Sahaphong; V Vathanophas; T Stitnimankarn
Journal:  Biometals       Date:  1996-04       Impact factor: 2.949

3.  Liver disease in transfusion dependent thalassaemia major.

Authors:  C K Li; K W Chik; C W K Lam; K F To; S C H Yu; V Lee; M M K Shing; A Y K Cheung; P M P Yuen
Journal:  Arch Dis Child       Date:  2002-05       Impact factor: 3.791

4.  Effect of deferasirox chelation on liver iron and total body iron concentration.

Authors:  Javed Ahmed; Noor Ahmad; Bhavin Jankharia; Pradeep Krishnan; Rashid H Merchant
Journal:  Indian J Pediatr       Date:  2013-05-29       Impact factor: 1.967

5.  Hepatitis B or non-A, non-B virus infection in multitransfused thalassaemic patients.

Authors:  G A Moroni; G Piacentini; S Terzoli; G Jean; G Masera
Journal:  Arch Dis Child       Date:  1984-12       Impact factor: 3.791

6.  Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine.

Authors:  M A Aldouri; B Wonke; A V Hoffbrand; D M Flynn; M Laulicht; L A Fenton; P J Scheuer; C C Kibbler; C A Allwood; D Brown
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

7.  Management of transfusional iron overload - differential properties and efficacy of iron chelating agents.

Authors:  Janet L Kwiatkowski
Journal:  J Blood Med       Date:  2011-09-21

8.  Secondary haemochromatosis in a patient with thalassemia intermedia.

Authors:  Ionela Rotaru; Amelia Gaman; G Gaman
Journal:  Curr Health Sci J       Date:  2013-12-29

9.  Comparative effects of three iron chelation therapies on the quality of life of greek patients with homozygous transfusion-dependent Beta-thalassemia.

Authors:  Vasilis Goulas; Alexandra Kourakli-Symeonidis; Charalambos Camoutsis
Journal:  ISRN Hematol       Date:  2012-12-17

10.  Longitudinal Study on Liver Functions in Patients with Thalassemia Major before and after Deferasirox (DFX) Therapy.

Authors:  Ashraf Soliman; Mohamed Yassin; Fawzia Al Yafei; Lolwa Al-Naimi; Noora Almarri; Aml Sabt; Vincenzo De Sanctis
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-04-07       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.